Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 3
1964 1
1965 23
1966 40
1967 38
1968 50
1969 64
1970 61
1971 67
1972 76
1973 104
1974 86
1975 70
1976 72
1977 83
1978 58
1979 61
1980 55
1981 48
1982 43
1983 38
1984 58
1985 40
1986 54
1987 46
1988 34
1989 25
1990 39
1991 31
1992 28
1993 25
1994 47
1995 28
1996 22
1997 31
1998 33
1999 43
2000 69
2001 74
2002 93
2003 141
2004 121
2005 145
2006 132
2007 111
2008 100
2009 131
2010 147
2011 128
2012 144
2013 157
2014 151
2015 154
2016 150
2017 128
2018 111
2019 117
2020 119
2021 91
2022 46
Text availability
Article attribute
Article type
Publication date

Search Results

4,174 results
Results by year
Filters applied: . Clear all
Page 1
Spironolactone for treatment of female pattern hair loss.
Burns LJ, De Souza B, Flynn E, Hagigeorges D, Senna MM. Burns LJ, et al. J Am Acad Dermatol. 2020 Jul;83(1):276-278. doi: 10.1016/j.jaad.2020.03.087. Epub 2020 Apr 5. J Am Acad Dermatol. 2020. PMID: 32259535 No abstract available.
Proteomic and Mechanistic Analysis of Spironolactone in Patients at Risk for HF.
Ferreira JP, Verdonschot J, Wang P, Pizard A, Collier T, Ahmed FZ, Brunner-La-Rocca HP, Clark AL, Cosmi F, Cuthbert J, Díez J, Edelmann F, Girerd N, González A, Grojean S, Hazebroek M, Khan J, Latini R, Mamas MA, Mariottoni B, Mujaj B, Pellicori P, Petutschnigg J, Pieske B, Rossignol P, Rouet P, Staessen JA, Cleland JGF, Heymans S, Zannad F; HOMAGE (Heart Omics in AGEing) Consortium. Ferreira JP, et al. JACC Heart Fail. 2021 Apr;9(4):268-277. doi: 10.1016/j.jchf.2020.11.010. Epub 2021 Feb 3. JACC Heart Fail. 2021. PMID: 33549556 Free article. Clinical Trial.
The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart 'OMics' in AGEing (HOMAGE) randomized clinical trial.
Cleland JGF, Ferreira JP, Mariottoni B, Pellicori P, Cuthbert J, Verdonschot JAJ, Petutschnigg J, Ahmed FZ, Cosmi F, Brunner La Rocca HP, Mamas MA, Clark AL, Edelmann F, Pieske B, Khan J, McDonald K, Rouet P, Staessen JA, Mujaj B, González A, Diez J, Hazebroek M, Heymans S, Latini R, Grojean S, Pizard A, Girerd N, Rossignol P, Collier TJ, Zannad F; HOMAGE Trial Committees and Investigators. Cleland JGF, et al. Eur Heart J. 2021 Feb 11;42(6):684-696. doi: 10.1093/eurheartj/ehaa758. Eur Heart J. 2021. PMID: 33215209 Free PMC article. Clinical Trial.
Spironolactone for hypertension.
Batterink J, Stabler SN, Tejani AM, Fowkes CT. Batterink J, et al. Cochrane Database Syst Rev. 2010 Aug 4;(8):CD008169. doi: 10.1002/14651858.CD008169.pub2. Cochrane Database Syst Rev. 2010. PMID: 20687095 Review.
Spironolactone.
Danby FW. Danby FW. J Am Acad Dermatol. 1992 Jan;26(1):137. doi: 10.1016/s0190-9622(08)80534-8. J Am Acad Dermatol. 1992. PMID: 1580900 No abstract available.
4,174 results